Type 1 Diabetes clinical trials
Showing 201–210 of 210 active trials. Describe your situation to see which ones you may be eligible for.
- Remedy to Diabetes Distress (R2D2): A Scalable Screen to Treat Program for School-age Families
- Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes
- The PRECISION II Study: Evaluating the Accuracy of the LabPatch Glucose Sensing System
- Pathogenesis of Kidney Disease in Type 1 Diabetes: a Modern Kidney Biopsy Cohort (The PANDA Study)
- Physiologic Markers of Cardiometabolic Risk in People With Type 1 Diabetes
- Implementing the Spotlight AQ Platform in Adolescent/ Young Adult (16-25 Years Old) Type 1 Diabetics (T1D)
- Game-based Pediatric Diabetes Education
- Reducing Diabetes Distress Using Cognitive Behavioral Therapy in Young Adults With Type 1 Diabetes
- Device Use Reimagined Through Education And Mentorship
- Resistance Training in Type 1 Diabetes Mellitus
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.